As of 2025-09-18, the Intrinsic Value of ALX Oncology Holdings Inc (ALXO) is -10.88 USD. This ALXO valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.05 USD, the upside of ALX Oncology Holdings Inc is -1,136.62%.
Based on its market price of 1.05 USD and our intrinsic valuation, ALX Oncology Holdings Inc (ALXO) is overvalued by 1,136.62%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -10.88 - -10.88 | -10.88 | -1,136.62% |
| P/E | (24.21) - (33.92) | (30.15) | -2971.4% |
| DDM - Stable | (20.63) - (81.22) | (50.93) | -4950.1% |
| DDM - Multi | (22.18) - (69.03) | (33.71) | -3310.1% |
| Market Cap (mil) | 56.23 |
| Beta | 1.23 |
| Outstanding shares (mil) | 53.55 |
| Enterprise Value (mil) | 49.16 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.90% |
| Cost of Debt | 5.00% |
| WACC | 8.17% |